Travaux et publications
2018
Early tumour response as a survival predictor in previously- treated patients receiving triplet hepatic artery infusion and intravenous cetuximab for unresectable liver metastases from wild-type KRAS colorectal cancer.
Bouchahda M, Boige V, Smith D, Ka - Eur J Cancer. 2016 Nov;68:163-172. doi: 10.1016/j.ejca.2016.09.011.
2016
Co-investigateur à l’étude STOP-HCC : essai de phase III évaluant THERASPHERE® INTRA-ARTÉRIEL pour le traitement des patients présentant un CHC non résécable avec deux bras de traitement (Yittrium90 + Sorafenib versus Sorafenib seul)
2016
Arterio-venous fistula for automated red blood cells exchange in patients with sickle cell disease: Complications and outcomes.
Delville M, Manceau S, Ait Abdallah N, Stolba J, Awad S, Damy T, Gellen B, Sabbah L, Debbache K, Audard V, Beaumont JL, Arna - Am J Hematol. 2017 Feb;92(2):136-140. doi: 10.1002/ajh.24600.
2013
Co-investigateur à l’étude HEPASPHERE : PHASE 3 PROSPECTIVE, RANDOMIZED, BLINDED AND CONTROLLED INVESTIGATION OF HEPASPHERE/QUADRASPHERE MICROSPHERES FORDELIVERY OF DOXORUBICIN FOR THE TREATMENT OF HEPATOCELLULAR CANCER
2012
Intention-to-treat analysis of percutaneous endovascular treatment of hepatic artery stenosis after orthotopic liver transplantation.
Rajakannu M, Awad S, Ciacio O, Pittau G, Adam R, Cunha AS, Castaing D, Samuel D, Lewin M, Cherqui D, Vibert E.
Prosp - Cardiovasc Intervent Radiol. 2010 Feb;33(1):41-52. doi: 10.1007/s00270-009-9711-7